期刊文献+

我国三城市医务人员对艾滋病暴露前药物预防知识知晓情况 被引量:7

Knowledge awareness of HIV pre-exposure prophylaxis(PrEP)among medical staff in three cities of China
原文传递
导出
摘要 目的了解我国三城市医务人员对艾滋病暴露前药物预防(PrEP)知识知晓情况。方法采用问卷调查方式收集北京、深圳、昆明三个城市的五家传染病医院医务人员的基本情况、艾滋病防治基本知识知晓、PrEP知识知晓情况,以及相关影响因素。结果共调查了1851名医务人员,平均年龄为34岁,女性占79.6%(1474名);医生占36.3%,护士占45.2%;非手术临床科室占47.4%,57.0%从事过艾滋病防治相关工作。医务人员的艾滋病防治基本知识知晓率为98.5%;71.4%听说过PrEP,PrEP知识知晓率为16.3%。从事过艾滋病防治工作的医务人员PrEP知晓比例显著高于其他人。结论医务人员对于PrEP的正确认知仍有不足,需有针对性地对不同岗位和专业的医务人员开展PrEP知识和咨询技能培训。 Objective To learn about the knowledge awareness of HIV pre-exposure prophylaxis(PrEP)among medical staff in three cities of China.Methods A questionnaire was designed to collect the information on knowledge awareness of HIV/AIDS prevention and treatment,PrEP and related influence factors of medical staff in five infectious diseases hospitals of Beijing,Shenzhen and Kunming.Results A total of 1851 medical workers were surveyed.The average age was 34 years,and 79.6%(1474)were female.Doctors accounted for 36.3%and nurses for 45.2%.Those from non-surgical clinical departments accounted for 47.4%,and 57%were engaged in AIDS prevention and treatment.The rate of knowledge awareness of AIDS prevention and treatment among medical staff was 98.5%.71.4%had heard of PrEP,16.3%had knowledge of PrEP.The awareness rate of PrEP among medical staff engaged in AIDS prevention and treatment was significantly higher than those of others.Conclusion Medical staff still need publicity and education of PrEP knowledge,and further training is necessary to carry out for them.
作者 王小芳 李杰 孙丽君 刘安 于艳平 陈子亮 姜天俊 宋兵 王辉 刘晓宁 刘俊 张广 WANG Xiao fang;LI Jie;SUN Lijun;LIU An;YU Yanping;CHEN Ziliang;JIANG Tianjun;SONG Bing;WANG Hui;LIU Xiaoning;LIU Jun;ZHANG Guang(National Center for STD/AIDS Con trol and Prevention,Beijing 102206,China;Chinese Association for STD and AIDS Prevention and Control,Beijing 100050;Beijing Youan Hospital Affiliated to Capital Medical University,Beijing 100069;Bei jing Ditan Hospital Affiliated Capital Medical University,Beijing 100015;General Hospital of PLA Fifth Medical Center,Beijing 100039;The Third Peopled Hospital of Shenzhen,Shenzhen 518112;The Third People's Hospital of Kunming,Kunming 650041,Yunnan)
出处 《中国艾滋病性病》 CAS CSCD 北大核心 2019年第12期1246-1249,1257,共5页 Chinese Journal of Aids & STD
关键词 艾滋病 暴露前药物预防 医务人员 AIDS PrEP medical staff
  • 相关文献

参考文献8

二级参考文献108

  • 1刘靖,王林.抗逆转录病毒药物的肝毒性[J].国外医学(药学分册),2005,32(5):335-338. 被引量:10
  • 2Thomas C. Roadblocks in HIV research: five questions[J]. Nat Meal,2009, 15(8): 855-859.
  • 3White RG, Glynn JR, Orroth KK et al. Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? [J].AIDS,2008, 22(14): 1841-1850.
  • 4Weiss HA, Hankins CA, Dickson K. Male circumcision and risk of HIV infection in women: a systematic review and recta-analysis [J]. Lancet Infect Dis,2009, 9(11): 669-677.
  • 5Wang L, Wang N, Li D et al. The 2007 Estimates for People at Risk for and Living With HIV in China: Progress and Challenges [J]. J Acquir Immune Defic Syndr,2009, 50(4): 414-418.
  • 6Derdelinckx I, Wainberg MA, Lange JM et al. Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection[J]. PLoS Med,2006, 3(11): e454.
  • 7Imrie J, Elford J, Kippax S et al. Biomedical HIV prevention-and social science[J]. Lancet,2007, 370(9581): 10--11.
  • 8Paltiel AD, Freedberg KA, Scott CA et al. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost effectiveness[J]. Clin Infect Dis,2009, 48(6), 806--815.
  • 9Gilead Sciences, Inc. highlights of prescribing information [OL]. 2008 Nov. avilable at : http://www, gilead, com/pdf/ viread_pi, pdf.
  • 10Borroto-Esoda K, Vela JE, Myrick F et al. In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtrieitabine[J].Antivir Ther,2006, 11(3) : 377-384.

共引文献76

同被引文献37

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部